| Year |
Citation |
Score |
| 2023 |
Brake ME, Russ BP, Gansebom S, Genzer SC, Tansey C, York IA. Effects of Extended-Release Buprenorphine on Mouse Models of Influenza. Comparative Medicine. PMID 38110195 DOI: 10.30802/AALAS-CM-23-000049 |
0.391 |
|
| 2023 |
Lu X, Liu F, Tzeng WP, York IA, Tumpey T, Levine MZ. Antibody-mediated Suppression Regulates the Humoral Immune Response to Influenza Vaccination in Humans. The Journal of Infectious Diseases. PMID 37981659 DOI: 10.1093/infdis/jiad493 |
0.442 |
|
| 2023 |
Guo Z, Lu X, Carney PJ, Chang J, Tzeng WP, York IA, Levine MZ, Stevens J. Use of Biolayer Interferometry to Identify Dominant Binding Epitopes of Influenza Hemagglutinin Protein of A(H1N1)pdm09 in the Antibody Response to 2010-2011 Influenza Seasonal Vaccine. Vaccines. 11. PMID 37631875 DOI: 10.3390/vaccines11081307 |
0.536 |
|
| 2023 |
Kieran TJ, DaSilva J, Stark TJ, York IA, Pappas C, Barnes JR, Maines TR, Belser JA. Influenza A Virus Multicycle Replication Yields Comparable Viral Population Emergence in Human Respiratory and Ocular Cell Types. Microbiology Spectrum. e0116623. PMID 37404140 DOI: 10.1128/spectrum.01166-23 |
0.404 |
|
| 2022 |
Levine MZ, Holiday C, Bai Y, Zhong W, Liu F, Jefferson S, Gross FL, Tzeng WP, Fries L, Smith G, Boutet P, Friel D, Innis BL, Mallett CP, Davis CT, ... ... York IA, et al. Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity. Vaccines. 10. PMID 36366364 DOI: 10.3390/vaccines10111856 |
0.498 |
|
| 2022 |
Lu X, Guo Z, Li ZN, Holiday C, Liu F, Jefferson S, Gross FL, Tzeng WP, Kumar A, York IA, Uyeki TM, Tumpey T, Stevens J, Levine MZ. Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection. Scientific Reports. 12: 14971. PMID 36056075 DOI: 10.1038/s41598-022-18977-0 |
0.37 |
|
| 2022 |
Alymova IV, Cipollo JF, Parsons LM, Music N, Kamal RP, Tzeng WP, Goldsmith CS, Contessa JN, Hartshorn KL, Wilson JR, Zeng H, Gansebom S, York IA. Aberrant Cellular Glycosylation May Increase the Ability of Influenza Viruses to Escape Host Immune Responses through Modification of the Viral Glycome. Mbio. e0298321. PMID 35285699 DOI: 10.1128/mbio.02983-21 |
0.814 |
|
| 2021 |
Patel MM, York IA, Monto AS, Thompson MG, Fry AM. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. The Lancet. Microbe. 2: e715-e725. PMID 35544110 DOI: 10.1016/S2666-5247(21)00180-4 |
0.501 |
|
| 2019 |
Music N, Tzeng WP, Liaini Gross F, Levine MZ, Xu X, Shieh WJ, Tumpey TM, Katz JM, York IA. Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets. Npj Vaccines. 4: 28. PMID 31312528 DOI: 10.1038/s41541-019-0123-7 |
0.508 |
|
| 2019 |
York IA, Stevens J, Alymova IV. Influenza virus N-linked glycosylation and innate immunity. Bioscience Reports. 39. PMID 30552137 DOI: 10.1042/Bsr20171505 |
0.56 |
|
| 2018 |
Sayedahmed EE, Kumari R, Shukla S, Hassan AO, Mohammed SI, York IA, Gangappa S, Sambhara S, Mittal SK. Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy. Vaccine. PMID 30266488 DOI: 10.1016/J.Vaccine.2018.09.031 |
0.529 |
|
| 2018 |
Sayedahmed EE, Hassan AO, Kumari R, Cao W, Gangappa S, York I, Sambhara S, Mittal SK. A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose. Molecular Therapy. Methods & Clinical Development. 10: 210-222. PMID 30101154 DOI: 10.1016/J.Omtm.2018.07.007 |
0.607 |
|
| 2018 |
Guo Z, Wilson JR, York IA, Stevens J. Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus. Journal of Immunological Methods. PMID 30053389 DOI: 10.1016/J.Jim.2018.07.007 |
0.517 |
|
| 2018 |
Liu F, Tzeng WP, Horner L, Kamal RP, Tatum HR, Blanchard EG, Xu X, York I, Tumpey TM, Katz JM, Lu X, Levine MZ. Both Immune Priming and Egg-adaptation in the Vaccine Influence Antibody Responses to Circulating A(H1N1)pdm09 Viruses Following Influenza Vaccination in Adults. The Journal of Infectious Diseases. PMID 29931203 DOI: 10.1093/Infdis/Jiy376 |
0.812 |
|
| 2018 |
Alymova IV, McCullers JA, Kamal RP, Vogel P, Green AM, Gansebom S, York IA. Virulent PB1-F2 residues: effects on fitness of H1N1 influenza A virus in mice and changes during evolution of human influenza A viruses. Scientific Reports. 8: 7474. PMID 29749408 DOI: 10.1038/S41598-018-25707-Y |
0.797 |
|
| 2018 |
Reber AJ, Music N, Kim JH, Gansebom S, Chen J, York I. Extensive T cell cross-reactivity between diverse seasonal influenza strains in the ferret model. Scientific Reports. 8: 6112. PMID 29666412 DOI: 10.1038/S41598-018-24394-Z |
0.482 |
|
| 2017 |
Kamal RP, Alymova IV, York IA. Evolution and Virulence of Influenza A Virus Protein PB1-F2. International Journal of Molecular Sciences. 19. PMID 29286299 DOI: 10.3390/Ijms19010096 |
0.778 |
|
| 2017 |
Hassan AO, Amen O, Sayedahmed EE, Vemula SV, Amoah S, York I, Gangappa S, Sambhara S, Mittal SK. Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses. Plos One. 12: e0186244. PMID 29023601 DOI: 10.1371/Journal.Pone.0186244 |
0.608 |
|
| 2017 |
Wilson JR, Belser JA, DaSilva J, Guo Z, Sun X, Gansebom S, Bai Y, Stark TJ, Chang J, Carney P, Levine MZ, Barnes J, Stevens J, Maines TR, Tumpey TM, ... York IA, et al. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge. Virology. 511: 214-221. PMID 28888111 DOI: 10.1016/J.Virol.2017.08.016 |
0.555 |
|
| 2017 |
Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA. Inactivated H7 influenza virus vaccines protect mice despite low levels of neutralizing antibodies. Journal of Virology. PMID 28768855 DOI: 10.1128/Jvi.01202-17 |
0.82 |
|
| 2017 |
Sun X, Belser JA, Pulit-Penaloza JA, Creager HM, Guo Z, Jefferson SN, Liu F, York IA, Stevens J, Maines TR, Jernigan DB, Katz JM, Levine MZ, Tumpey TM. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets. Virology. 508: 164-169. PMID 28554058 DOI: 10.1016/J.Virol.2017.05.010 |
0.624 |
|
| 2017 |
Kumar A, Kim JH, Ranjan P, Metcalfe MG, Cao W, Mishina M, Gangappa S, Guo Z, Boyden ES, Zaki S, York I, García-Sastre A, Shaw M, Sambhara S. Influenza virus exploits tunneling nanotubes for cell-to-cell spread. Scientific Reports. 7: 40360. PMID 28059146 DOI: 10.1038/Srep40360 |
0.538 |
|
| 2016 |
Kim JH, Reber AJ, Kumar A, Ramos P, Sica G, Music N, Guo Z, Mishina M, Stevens J, York IA, Jacob J, Sambhara S. Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease. Scientific Reports. 6: 37341. PMID 27849030 DOI: 10.1038/Srep37341 |
0.61 |
|
| 2016 |
Alymova IV, York IA, Air GM, Cipollo JF, Gulati S, Baranovich T, Kumar A, Zeng H, Gansebom S, McCullers JA. Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence. Scientific Reports. 6: 36216. PMID 27796371 DOI: 10.1038/Srep36216 |
0.49 |
|
| 2016 |
Wilson JR, Guo Z, Reber A, Kamal RP, Music N, Gansebom S, Bai Y, Levine M, Carney P, Tzeng WP, Stevens J, York IA. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo. Antiviral Research. PMID 27713074 DOI: 10.1016/J.Antiviral.2016.10.001 |
0.793 |
|
| 2016 |
Zhong W, Liu F, Wilson JR, Holiday C, Li ZN, Bai Y, Tzeng WP, Stevens J, York IA, Levine MZ. Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans. Open Forum Infectious Diseases. 3: ofw102. PMID 27419174 DOI: 10.1093/Ofid/Ofw102 |
0.627 |
|
| 2016 |
Music N, Reber AJ, Kim JH, York IA. Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus. Plos One. 11: e0157903. PMID 27315117 DOI: 10.1371/Journal.Pone.0157903 |
0.433 |
|
| 2016 |
Cao W, Liepkalns JS, Kamal RP, Reber AJ, Kim JH, Hofstetter AR, Amoah S, Stevens J, Ranjan P, Gangappa S, York IA, Sambhara S. RIG-I ligand enhances the immunogenicity of recombinant H7HA protein. Cellular Immunology. PMID 27106062 DOI: 10.1016/J.Cellimm.2016.04.004 |
0.813 |
|
| 2016 |
Cao W, Liepkalns J, Hassan AO, Kamal R, Hofstetter AR, Amoah S, Kim JH, Reber A, Stevens J, Katz JM, Gangappa S, York I, Mittal SK, Sambhara S. A highly immunogenic vaccine against A(H7N9) influenza virus. Vaccine. PMID 26765287 DOI: 10.1016/J.Vaccine.2015.12.062 |
0.819 |
|
| 2015 |
Music N, Reber AJ, Kim MC, York IA, Kang SM. Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets. Vaccine. PMID 26709639 DOI: 10.1016/J.Vaccine.2015.12.023 |
0.559 |
|
| 2015 |
Wilson JR, Guo Z, Tzeng WP, Garten RJ, Xiyan X, Blanchard EG, Blanchfield K, Stevens J, Katz JM, York IA. Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus. Virology. 485: 252-262. PMID 26318247 DOI: 10.1016/J.Virol.2015.08.004 |
0.545 |
|
| 2015 |
Kamal RP, Kumar A, Davis CT, Tzeng WP, Nguyen T, Donis RO, Katz JM, York IA. Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice. Journal of Virology. 89: 5835-46. PMID 25787281 DOI: 10.1128/Jvi.03137-14 |
0.763 |
|
| 2015 |
Hearn C, Preeyanon L, Hunt HD, York IA. An MHC class I immune evasion gene of Marek׳s disease virus. Virology. 475: 88-95. PMID 25462349 DOI: 10.1016/J.Virol.2014.11.008 |
0.365 |
|
| 2014 |
Alymova IV, York IA, McCullers JA. Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers. Plos One. 9: e111603. PMID 25368997 DOI: 10.1371/Journal.Pone.0111603 |
0.504 |
|
| 2014 |
Blanchfield K, Kamal RP, Tzeng WP, Music N, Wilson JR, Stevens J, Lipatov AS, Katz JM, York IA. Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins. Influenza and Other Respiratory Viruses. 8: 628-35. PMID 25213778 DOI: 10.1111/Irv.12285 |
0.817 |
|
| 2014 |
Kamal RP, Katz JM, York IA. Molecular determinants of influenza virus pathogenesis in mice. Current Topics in Microbiology and Immunology. 385: 243-74. PMID 25038937 DOI: 10.1007/82_2014_388 |
0.802 |
|
| 2014 |
Music N, Reber AJ, Lipatov AS, Kamal RP, Blanchfield K, Wilson JR, Donis RO, Katz JM, York IA. Influenza vaccination accelerates recovery of ferrets from lymphopenia. Plos One. 9: e100926. PMID 24968319 DOI: 10.1371/Journal.Pone.0100926 |
0.803 |
|
| 2014 |
Wilson JR, Tzeng WP, Spesock A, Music N, Guo Z, Barrington R, Stevens J, Donis RO, Katz JM, York IA. Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin. Virology. 458: 114-24. PMID 24928044 DOI: 10.1016/J.Virol.2014.04.011 |
0.599 |
|
| 2014 |
Shepard SS, Davis CT, Bahl J, Rivailler P, York IA, Donis RO. LABEL: fast and accurate lineage assignment with assessment of H5N1 and H9N2 influenza A hemagglutinins. Plos One. 9: e86921. PMID 24466291 DOI: 10.1371/Journal.Pone.0086921 |
0.425 |
|
| 2014 |
Music N, Reber AJ, Lipatov AS, Kamal RP, Blanchfield K, Wilson JR, Donis RO, Katz JM, York IA. Influenza vaccination accelerates recovery of ferrets from lymphopenia Plos One. 9. DOI: 10.1371/journal.pone.0100926 |
0.789 |
|
| 2013 |
Seregin SS, Rastall DP, Evnouchidou I, Aylsworth CF, Quiroga D, Kamal RP, Godbehere-Roosa S, Blum CF, York IA, Stratikos E, Amalfitano A. Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens. Autoimmunity. 46: 497-508. PMID 24028501 DOI: 10.3109/08916934.2013.819855 |
0.715 |
|
| 2013 |
York I, Donis RO. The 2009 pandemic influenza virus: where did it come from, where is it now, and where is it going? Current Topics in Microbiology and Immunology. 370: 241-57. PMID 22638836 DOI: 10.1007/82_2012_221 |
0.572 |
|
| 2012 |
Nguyen T, Rivailler P, Davis CT, Hoa do T, Balish A, Dang NH, Jones J, Vui DT, Simpson N, Huong NT, Shu B, Loughlin R, Ferdinand K, Lindstrom SE, York IA, et al. Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010. Virology. 432: 405-16. PMID 22818871 DOI: 10.1016/J.Virol.2012.06.021 |
0.534 |
|
| 2012 |
Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, Chen LM, Recuenco S, Ellison JA, Davis CT, York IA, Turmelle AS, Moran D, Rogers S, Shi M, Tao Y, et al. A distinct lineage of influenza A virus from bats. Proceedings of the National Academy of Sciences of the United States of America. 109: 4269-74. PMID 22371588 DOI: 10.1073/Pnas.1116200109 |
0.574 |
|
| 2012 |
Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, Delgado JC, Welsh RM, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rock KL. Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nature Immunology. 13: 129-35. PMID 22197977 DOI: 10.1038/Ni.2203 |
0.333 |
|
| 2011 |
Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. Plos One. 6: e25333. PMID 22031815 DOI: 10.1371/Journal.Pone.0025333 |
0.555 |
|
| 2011 |
Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, Compans RW, York I, Kang SM, Donis RO. Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza. Clinical and Vaccine Immunology : Cvi. 18: 2010-7. PMID 22030367 DOI: 10.1128/Cvi.05206-11 |
0.605 |
|
| 2011 |
Spesock A, Malur M, Hossain MJ, Chen LM, Njaa BL, Davis CT, Lipatov AS, York IA, Krug RM, Donis RO. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. Journal of Virology. 85: 7048-58. PMID 21593152 DOI: 10.1128/Jvi.00417-11 |
0.491 |
|
| 2011 |
Evnouchidou I, Kamal RP, Seregin SS, Goto Y, Tsujimoto M, Hattori A, Voulgari PV, Drosos AA, Amalfitano A, York IA, Stratikos E. Cutting Edge: Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. Journal of Immunology (Baltimore, Md. : 1950). 186: 1909-13. PMID 21242517 DOI: 10.4049/Jimmunol.1003337 |
0.713 |
|
| 2010 |
Georgiadou D, Hearn A, Evnouchidou I, Chroni A, Leondiadis L, York IA, Rock KL, Stratikos E. Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1. Journal of Immunology (Baltimore, Md. : 1950). 185: 1584-92. PMID 20592285 DOI: 10.4049/Jimmunol.0902502 |
0.332 |
|
| 2010 |
Dang Y, Wang X, York IA, Zheng YH. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. Journal of Virology. 84: 8561-70. PMID 20592083 DOI: 10.1128/Jvi.00960-10 |
0.305 |
|
| 2010 |
Dang Y, Davis RW, York IA, Zheng YH. Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity. Journal of Virology. 84: 5741-50. PMID 20335268 DOI: 10.1128/Jvi.00079-10 |
0.324 |
|
| 2009 |
Kawahara M, York IA, Hearn A, Farfan D, Rock KL. Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo. Journal of Immunology (Baltimore, Md. : 1950). 183: 6069-77. PMID 19841172 DOI: 10.4049/Jimmunol.0803564 |
0.372 |
|
| 2009 |
Hearn A, York IA, Rock KL. The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum. Journal of Immunology (Baltimore, Md. : 1950). 183: 5526-36. PMID 19828632 DOI: 10.4049/Jimmunol.0803663 |
0.311 |
|
| 2008 |
Towne CF, York IA, Neijssen J, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Neefjes JJ, Rock KL. Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell responses during viral infections. Journal of Immunology (Baltimore, Md. : 1950). 180: 1704-12. PMID 18209067 DOI: 10.4049/Jimmunol.180.3.1704 |
0.34 |
|
| 2007 |
Towne CF, York IA, Watkin LB, Lazo JS, Rock KL. Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 178: 6923-30. PMID 17513741 DOI: 10.4049/Jimmunol.178.11.6923 |
0.376 |
|
| 2006 |
York IA, Bhutani N, Zendzian S, Goldberg AL, Rock KL. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation. Journal of Immunology (Baltimore, Md. : 1950). 177: 1434-43. PMID 16849449 DOI: 10.4049/Jimmunol.177.3.1434 |
0.313 |
|
| 2006 |
York IA, Brehm MA, Zendzian S, Towne CF, Rock KL. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proceedings of the National Academy of Sciences of the United States of America. 103: 9202-7. PMID 16754858 DOI: 10.1073/Pnas.0603095103 |
0.352 |
|
| 2005 |
Towne CF, York IA, Neijssen J, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Neefjes JJ, Rock KL. Leucine aminopeptidase is not essential for trimming peptides in the cytosol or generating epitopes for MHC class I antigen presentation. Journal of Immunology (Baltimore, Md. : 1950). 175: 6605-14. PMID 16272315 DOI: 10.4049/Jimmunol.175.10.6605 |
0.359 |
|
| 2004 |
Rock KL, York IA, Goldberg AL. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nature Immunology. 5: 670-7. PMID 15224092 DOI: 10.1038/Ni1089 |
0.323 |
|
| 2003 |
York IA, Mo AX, Lemerise K, Zeng W, Shen Y, Abraham CR, Saric T, Goldberg AL, Rock KL. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity. 18: 429-40. PMID 12648459 DOI: 10.1016/S1074-7613(03)00058-X |
0.32 |
|
| 2002 |
York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, Rock KL. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nature Immunology. 3: 1177-84. PMID 12436110 DOI: 10.1038/Ni860 |
0.311 |
|
| 2002 |
Rock KL, York IA, Saric T, Goldberg AL. Protein degradation and the generation of MHC class I-presented peptides. Advances in Immunology. 80: 1-70. PMID 12078479 DOI: 10.1016/S0065-2776(02)80012-8 |
0.316 |
|
| 2000 |
York IA, Goldberg AL, Mo XY, Rock KL. Proteolysis and class I major histocompatibility complex antigen presentation. Immunological Reviews. 172: 49-66. PMID 10631936 DOI: 10.1111/J.1600-065X.1999.Tb01355.X |
0.326 |
|
| 1997 |
York IA. Immune evasion strategies of the herpesviruses. Chemistry & Biology. 3: 331-5. PMID 8807861 DOI: 10.1016/S1074-5521(96)90115-5 |
0.365 |
|
| 1996 |
York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Annual Review of Immunology. 14: 369-96. PMID 8717519 DOI: 10.1146/Annurev.Immunol.14.1.369 |
0.302 |
|
| 1995 |
Levatte MA, Weaver LC, York IA, Johnson D, Dekaban GA. Delivery of a foreign gene to sympathetic preganglionic neurons using recombinant herpes simplex virus. Neuroscience. 66: 737-50. PMID 7644034 DOI: 10.1016/0306-4522(94)00617-E |
0.311 |
|
| Show low-probability matches. |